Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 2, 2007, Pages 739-748

  Smothers, C Thetford ^a   Woodward, John J ^a,b  

^a MUSC Center for Drug and Alcohol Programs   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 5,7 DICHLOROKYNURENIC ACID; 7 CHLOROKYNURENIC ACID; ACAMPROSATE; ALCOHOL; DEXTRO SERINE; DIZOCILPINE; GLUTAMIC ACID; GLYCINE; GLYCINE RECEPTOR; GLYCINE TRANSPORTER; IFENPRODIL; KAINIC ACID; KETAMINE; MAGNESIUM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TOLUENE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; VOLTAGE CLAMP;

ALANINE; ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; KYNURENIC ACID; MEMBRANE POTENTIALS; MICE; MUTATION; PATCH-CLAMP TECHNIQUES; PYRROLIDINONES; RATS; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; SARCOSINE; STRYCHNINE; TRANSFECTION;

EID: 34547093859     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.123836     Document Type: Article

References (38)

1. Awobuluyi M, Yang J, Ye Y, Chatterton JE, Godzik A, Lipton SA, and Zhang D (2007) Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 "NMDA" receptors. Mol Pharmacol 71:112-122.
2. Bale AS, Meacham CA, Benignus VA, Bushnell PJ, and Shafer TJ (2005) Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. Toxicol Appl Pharmacol 205:77-88.
3. Baron BM, Harrison BL, Miller FP, McDonald IA, Salituro FG, Schmidt CJ, Sorensen SM, White HS, and Palfreyman MG (1990) Activity of 5,7- dichlorokynurenic acid, a potent antagonist at the N-methyl-D- aspartate receptor-associated glycine binding site. Mol Pharmacol 38:554-561.
4. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. Eur J Pharmacol 206:149-154.
5. Betz H and Laube B (2006) Glycine receptors: recent insights into their structural organization and functional diversity. J Neurochem 97:1600-1610.
6. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, and Zhang D(2002) Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415:793-798.
7. Chen HS and Lipton SA (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol 499:27-46.
8. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, and Sevarino KA (1995) Cloning and characterization of χ-1: A developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15:6498-6508.
9. Clements JD and Westbrook GL (1994) Kinetics of AP5 dissociation from NMDA receptors: evidence for two identical cooperative binding sites. J Neurophysiol 71:2566-2569.
10. Cruz SL, Balster RL, and Woodward JJ (2000) Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br J Pharmacol 131:1303-1308.
11. Cruz SL, Mirshahi T, Thomas B, Balster RL, and Woodward JJ (1998) Effects of the abused solvent toluene on recombinant N-methyl-D- aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334-340.
12. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, et al. (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393:377-381.
13. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
14. Freese TE, Miotto K, and Reback CJ (2002) The effects and consequences of selected club drugs. J Subst Abuse Treat 23:151-156.
15. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
16. Huettner JE and Bean BP (1988) Block of N-methyl-D- aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A 85:1307-1311.
17. Jin C and Woodward JJ (2006) Effects of 8 different NR1 splice variants on the ethanol inhibition of recombinant NMDA receptors. Alcohol Clin Exp Res 30:673-679.
18. Kurtzman TL, Otsuka KN, and Wahl RA (2001) Inhalant abuse by adolescents. J Adolesc Health 28:170-180.
19. Lovinger DM, White G, and Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724.
20. Madry C, Mesic I, Bartholomaus I, Nicke A, Betz H, and Laube B (2007) Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem Biophys Res Commun 354:102-108.
21. Matsuda K, Fletcher M, Kamiya Y, and Yuzaki M (2003) Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci 23:10064-10073.
22. Matsuda K, Kamiya Y, Matsuda S, and Yuzaki M (2002) Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res Mol Brain Res 100:43-52.
23. Nishi M, Hinds H, Lu HP, Kawata M, and Hayashi Y (2001) Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21:RC 185.
24. Ogata J, Shiraishi M, Namba T, Smothers CT, Woodward JJ, and Harris RA (2006) Effects of anesthetics on mutant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 318:434-443.
25. Orser BA, Pennefather PS, and MacDonald JF (1997) Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 86:903-917.
26. Peoples RW, White G, Lovinger DM, and Weight FF (1997) Ethanol inhibition of N-methyl-D-aspartate-activated current in mouse hippocampal neurones: whole-cell patch-clamp analysis. Br J Pharmacol 122:1035-1042.
27. Petrović M, Horak M, Sedlacek M and Vyklicky L Jr (2005) Physiology and pathology of NMDA receptors. Prague Med Rep 106:113-136.
28. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgansberger W, and Schadrack J (2001) The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40:749-760.
29. Ronald KM, Mirshahi T, and Woodward JJ (2001) Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue. J Biol Chem 276:44729-44735.
30. Smothers CT and Woodward JJ (2003) Effect of the NR3 subunit on ethanol inhibition of recombinant NMDA receptors. Brain Res 987:117-121.
31. Smothers CT and Woodward JJ (2006) Effects of amino acid substitutions in trans-membrane domains of the NR1 subunit on the ethanol inhibition of recombinant N-methyl-D-aspartate receptors. Alcohol Clin Exp Res 30:523-530.
32. Soloviev MM, Brierley MJ, Shao ZY, Mellor IR, Volkova TM, Kamboj R, Ishimaru H, Sudan H, Harris J, Foldes RL, et al. (1996) Functional expression of a recombinant unitary glutamate receptor from Xenopus, which contains N-methyl-D-aspartate (NMDA) and non-NMDA receptor subunits. J Biol Chem 271:32572-32579.
33. Sun LX, Margolis FL, Shipley MT, and Lidow MS (1998) Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett 441:392-396.
34. Wada A, Takahashi H, Lipton SA, and Chen HS (2006) NR3A modulates the outer vestibule of the "NMDA" receptor channel. J Neurosci 26:13156-13166.
35. Wafford KA, Kathoria M, Bain CJ, Marshall G, Le Bourdellès B, Kemp JA, and Whiting PJ (1995) Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol Pharmacol 47:374-380.
36. Williams K (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851-859.
37. Yamakura T, Askalany AR, Petrenko AB, Kohno T, Baba H, and Sakimura K (2005) The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors. Anesth Analg 100:1687-1692.
38. Yao Y and Mayer ML (2006) Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J Neurosci 26:4559-4566.